Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Bridge Builder Large Cap Value

FMI Large Cap Investor

Liberty All-Star Equity

Scharf Multi-Asset Composite

1832 AM U.S. Low Volatility Equity LP I

AMG River Road Small-Mid Cap Value N

Bridge Builder Tax Managed Large Cap

MassMutual Fundamental Value R5

abrdn World Healthcare

Mercer US Small/Mid Cap Equity Y3

Russell Inv Tax-Managed US Mid&Sm Cap S

SPDR® S&P Kensho New Economies Comps ETF

Scharf Quality Value

Barrow Hanley Dividend Focused Value Eq

1290 VT Equity Income IB

Heartland Mid Cap Value Institutional

MDPIM US Equity Pool

Strategic Advisers U.S. Total Stock

Buffalo International

Fiduciary Mgt of Milwaukee Lg-Cap Eq

Fiduciary Management, Inc. of Milwaukee

Barrow Hanley Mewhinney & Strauss LLC

DePrince Race & Zollo Inc

Wells Fargo & Co

Envestnet Asset Management Inc

Heartland Advisors Inc

FMR Inc

Dimensional Fund Advisors, Inc.

Bank of America Corp

Acadian Asset Management LLC

Bank of Montreal

BMO Capital Markets Corp.

Scharf Investments

Goldman Sachs Group Inc

TPG GP A, LLC

Morgan Stanley - Brokerage Accounts

River Road Asset Management, LLC

Brandes Investment Partners & Co

Clark Estates Inc

Jane Street Group LLC

Smith & Nephew SNATS Inc

Dr. Deepak S. Nath Ph.D.

CEO & Director

Mr. John Terence Rogers

CFO & Executive Director

Mr. Paul  Connolly

President of Global Operations

Mr. Andrew  Swift

Vice President of Investor Relations

Ms. Helen  Barraclough

Group General Counsel & Company Secretary

Ms. Alison  Parkes

Chief Compliance Officer & Compliance APAC

Mr. Joe  Metzger

Senior Vice President of Marketing Services & Communications

Mr. Philip G. Cowdy

Chief Corporate Development & Corporate Affairs Officer

Ms. Elga  Lohler

Chief Human Resources Officer

Dr. Vasant  Padmanabhan Ph.D.

President of Research & Development and Ear, Nose & Throat

SNN's next earnings is on February 25, 2025 (Before Market Open)

SNN's latest dividend is 0.288 USD on October 4, 2024

Smith & Nephew SNATS Inc (SNN) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Smith & Nephew SNATS Inc (SNN) Earnings Report Date and History | NYSE

SNN's next earnings is on February 25, 2025 (Before Market Open)

When is the earnings report for SNN?

SNN Earnings History

SNN's latest dividend is 0.288 USD on October 4, 2024

SNN Stock Discussion Forum and Message Board

News for NYSE: SNN